{"transactions":[{"id":2702803,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T16:18:44.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to the Option vested on January 1, 2013 (the \"First 2012 Vesting Commencement Date\") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2021-12-31","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001209191-21-034400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919121034400/doc4.xml","form_type":"4"}},{"id":2702802,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T16:18:44.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":1028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to the Option vested on January 1, 2013 (the \"First 2012 Vesting Commencement Date\") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2021-12-31","underlying":"Common Shares","underlying_shares":1028},"source":{"system":"sec-edgar","filing":"0001209191-21-034400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919121034400/doc4.xml","form_type":"4"}},{"id":2702801,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T16:18:44.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on July 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":3.87,"expiration_date":"2021-06-30","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001209191-21-034400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919121034400/doc4.xml","form_type":"4"}},{"id":2702800,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-05-20T16:18:44.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":5144,"price":3.67,"value":18878.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":77942,"source":{"system":"sec-edgar","filing":"0001209191-21-034400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919121034400/doc4.xml","form_type":"4"}},{"id":2702799,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-05-20T16:18:44.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":1028,"price":3.67,"value":3772.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":72798,"source":{"system":"sec-edgar","filing":"0001209191-21-034400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919121034400/doc4.xml","form_type":"4"}},{"id":2702798,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-05-20T16:18:44.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":2057,"price":3.87,"value":7960.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":71770,"source":{"system":"sec-edgar","filing":"0001209191-21-034400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919121034400/doc4.xml","form_type":"4"}},{"id":2998011,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-29T16:27:18.000Z","date":"2020-10-28","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2020-12-31","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001209191-20-056229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120056229/doc4.xml","form_type":"4"}},{"id":2998010,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-29T16:27:18.000Z","date":"2020-10-28","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2020-12-31","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001209191-20-056229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120056229/doc4.xml","form_type":"4"}},{"id":2998009,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-10-29T16:27:18.000Z","date":"2020-10-28","kind":"gift","acquired":false,"shares":10288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":69713,"source":{"system":"sec-edgar","filing":"0001209191-20-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120056229/doc4.xml","form_type":"4"}},{"id":2998008,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-10-29T16:27:18.000Z","date":"2020-10-28","kind":"exercise","acquired":true,"shares":5144,"price":3.76,"value":19341.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":80001,"source":{"system":"sec-edgar","filing":"0001209191-20-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120056229/doc4.xml","form_type":"4"}},{"id":2998007,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-10-29T16:27:18.000Z","date":"2020-10-28","kind":"exercise","acquired":true,"shares":5144,"price":3.76,"value":19341.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":74857,"source":{"system":"sec-edgar","filing":"0001209191-20-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120056229/doc4.xml","form_type":"4"}},{"id":3114486,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T17:17:55.000Z","date":"2020-06-09","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option fully vested on June 30, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.52,"expiration_date":"2020-07-01","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001209191-20-035608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120035608/doc4.xml","form_type":"4"}},{"id":3114485,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-06-10T17:17:55.000Z","date":"2020-06-09","kind":"exercise","acquired":true,"shares":5144,"price":3.52,"value":18106.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":69713,"source":{"system":"sec-edgar","filing":"0001209191-20-035608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120035608/doc4.xml","form_type":"4"}},{"id":3126687,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T17:19:06.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to\nthe Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year\nanniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":13.11,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-033643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919120033643/doc4.xml","form_type":"4"}},{"id":3360985,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-22T13:30:54.000Z","date":"2019-11-21","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on June 30, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.51,"expiration_date":"2020-06-30","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001209191-19-057754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119057754/doc4.xml","form_type":"4"}},{"id":3360984,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-22T13:30:54.000Z","date":"2019-11-21","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.56,"expiration_date":"2019-12-31","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001209191-19-057754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119057754/doc4.xml","form_type":"4"}},{"id":3360983,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T13:30:54.000Z","date":"2019-11-21","kind":"gift","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":64569,"source":{"system":"sec-edgar","filing":"0001209191-19-057754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119057754/doc4.xml","form_type":"4"}},{"id":3360982,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T13:30:54.000Z","date":"2019-11-21","kind":"exercise","acquired":true,"shares":2057,"price":3.51,"value":7220.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":66626,"source":{"system":"sec-edgar","filing":"0001209191-19-057754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119057754/doc4.xml","form_type":"4"}},{"id":3360981,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T13:30:54.000Z","date":"2019-11-21","kind":"gift","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":64569,"source":{"system":"sec-edgar","filing":"0001209191-19-057754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119057754/doc4.xml","form_type":"4"}},{"id":3360980,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T13:30:54.000Z","date":"2019-11-21","kind":"exercise","acquired":true,"shares":5144,"price":3.56,"value":18312.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":69713,"source":{"system":"sec-edgar","filing":"0001209191-19-057754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119057754/doc4.xml","form_type":"4"}},{"id":3410722,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T19:45:57.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-050172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000120919119050172/doc4.xml","form_type":"4"}},{"id":3513206,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-23T11:56:41.000Z","date":"2019-05-21","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option fully vested on December 31, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2019-06-30","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0000899243-19-014470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000089924319014470/doc4.xml","form_type":"4"}},{"id":3513205,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-05-23T11:56:41.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":2057,"price":3.21,"value":6602.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":64569,"source":{"system":"sec-edgar","filing":"0000899243-19-014470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000089924319014470/doc4.xml","form_type":"4"}},{"id":3718843,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-12-26T11:00:38.000Z","date":"2018-12-21","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":62512,"source":{"system":"sec-edgar","filing":"0001171843-18-008556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318008556/ownership.xml","form_type":"4"}},{"id":3884838,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T16:40:03.000Z","date":"2018-06-21","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on December 31, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.07,"expiration_date":"2018-12-31","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001171843-18-004796","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004796/formfour.xml","form_type":"4"}},{"id":3884837,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T16:40:03.000Z","date":"2018-06-21","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on June 30, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.66,"expiration_date":"2018-06-30","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001171843-18-004796","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004796/formfour.xml","form_type":"4"}},{"id":3884836,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T16:40:03.000Z","date":"2018-06-21","kind":"exercise","acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option fully vested on May 31, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2018-06-26","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0001171843-18-004796","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004796/formfour.xml","form_type":"4"}},{"id":3884835,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-06-22T16:40:03.000Z","date":"2018-06-21","kind":"exercise","acquired":true,"shares":5144,"price":3.07,"value":15792.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":67512,"source":{"system":"sec-edgar","filing":"0001171843-18-004796","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004796/formfour.xml","form_type":"4"}},{"id":3884834,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-06-22T16:40:03.000Z","date":"2018-06-21","kind":"exercise","acquired":true,"shares":2057,"price":3.66,"value":7528.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":62368,"source":{"system":"sec-edgar","filing":"0001171843-18-004796","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004796/formfour.xml","form_type":"4"}},{"id":3884833,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-06-22T16:40:03.000Z","date":"2018-06-21","kind":"exercise","acquired":true,"shares":5144,"price":3.7,"value":19032.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":60311,"source":{"system":"sec-edgar","filing":"0001171843-18-004796","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004796/formfour.xml","form_type":"4"}},{"id":3904933,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T16:42:06.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":6.2,"expiration_date":"2028-06-03","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001171843-18-004461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184318004461/form4.xml","form_type":"4"}},{"id":4276039,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-20T16:37:50.000Z","date":"2017-06-19","kind":"exercise","acquired":false,"shares":1028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on June 30, 2010."}],"balance_after":0,"derivative":{"exercise_price":3.51,"expiration_date":"2017-06-30","underlying":"Common Shares","underlying_shares":1028},"source":{"system":"sec-edgar","filing":"0001171843-17-003707","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184317003707/formfour.xml","form_type":"4"}},{"id":4276038,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-06-20T16:37:50.000Z","date":"2017-06-19","kind":"gift","acquired":false,"shares":1028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":55167,"source":{"system":"sec-edgar","filing":"0001171843-17-003707","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184317003707/formfour.xml","form_type":"4"}},{"id":4276037,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-06-20T16:37:50.000Z","date":"2017-06-19","kind":"exercise","acquired":true,"shares":1028,"price":3.51,"value":3608.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":56195,"source":{"system":"sec-edgar","filing":"0001171843-17-003707","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184317003707/formfour.xml","form_type":"4"}},{"id":4295534,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T16:58:30.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest 100% on the one year anniversary of the grant date."}],"balance_after":1250,"derivative":{"exercise_price":3.85,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001171843-17-003443","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184317003443/formfour.xml","form_type":"4"}},{"id":4295533,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T16:58:30.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":3500,"derivative":{"exercise_price":3.85,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001171843-17-003443","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184317003443/formfour.xml","form_type":"4"}},{"id":4479027,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-01-27T17:27:25.000Z","date":"2017-01-26","kind":"gift","acquired":false,"shares":7201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":55167,"source":{"system":"sec-edgar","filing":"0001171843-17-000509","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184317000509/formfour.xml","form_type":"4"}},{"id":4523623,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-13T16:57:07.000Z","date":"2016-12-12","kind":"exercise","acquired":false,"shares":14403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2009."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2016-12-31","underlying":"Common Shares","underlying_shares":14403},"source":{"system":"sec-edgar","filing":"0001171843-16-013622","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184316013622/formfour.xml","form_type":"4"}},{"id":4523622,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2016-12-13T16:57:07.000Z","date":"2016-12-12","kind":"gift","acquired":false,"shares":7202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were gifted to family members that do not share the reporting person's household."}],"balance_after":62368,"source":{"system":"sec-edgar","filing":"0001171843-16-013622","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184316013622/formfour.xml","form_type":"4"}},{"id":4523621,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":139185,"kind":"person","name":"TARNOW MICHAEL M","position":1,"cik":"0001263647","reported_name":"TARNOW MICHAEL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2016-12-13T16:57:07.000Z","date":"2016-12-12","kind":"exercise","acquired":true,"shares":14403,"price":3.21,"value":46233.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":69570,"source":{"system":"sec-edgar","filing":"0001171843-16-013622","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263647/000117184316013622/formfour.xml","form_type":"4"}}]}